Evidence map›Paper›PMID 31683896›Full record

ArticleCancers2019

Treatment Outcome of 227 Patients with Sinonasal Adenoid Cystic Carcinoma (ACC) after Intensity Modulated Radiotherapy and Active Raster-Scanning Carbon Ion Boost: A 10-Year Single-Center Experience.

Sati Akbaba, Dina Ahmed, Andreas Mock, Thomas Held, Suzan Bahadir, Kristin Lang, Mustafa Syed, Juliane Hoerner-Rieber, Tobias Forster, Philippe Federspil and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07563088 (Postoperative Adjuvant Radiotherapy Strategy for Resectable Sinonasal Adenoid Cystic Carcinoma), which is not on this map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07563088 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Postoperative Adjuvant Radiotherapy Strategy for Resectable Sinonasal Adenoid Cystic Carcinoma: A Prospective, Multicenter, Real-World Study

TypeobservationalSponsorEye & ENT Hospital of Fudan UniversityRan2026 to 2032Enrolled200ConditionsAdenoid Cystic Carcinoma, Sinonasal CarcinomaArmsPostoperative Radiotherapy, Observation
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. International journal of particle therapy · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Frontiers in oncology · 2021
    Article
  15. Review
  16. Article
  17. Article
  18. The 20th Gray lecture 2019: health and heavy ions.The British journal of radiology · 2020
    Review
  19. Particle therapy in the future of precision therapy.The British journal of radiology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Sati AkbabaDepartment of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. sebastian.adeberg@med.uni-heidelberg.de.ORCID 0000-0001-8363-2668
Dina AhmedDepartment of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. dina.ahmed@med.uni-heidelberg.de.
Andreas MockDepartment of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany. andreas.mock@med.uni-heidelberg.de.
Thomas HeldDepartment of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. thomas.held@med.uni-heidelberg.de.ORCID 0000-0002-3913-4693
Suzan BahadirDepartment of Radiology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. dr_suzanb@hotmail.com.ORCID 0000-0002-0019-5851
Kristin LangDepartment of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. kristin.lang@med.uni-heidelberg.de.
Mustafa SyedDepartment of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. mustafa.syed@med.uni-heidelberg.de.
Juliane Hoerner-RieberDepartment of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. juliane.hoerner-rieber@med.uni-heidelberg.de.
Tobias ForsterDepartment of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. tobias.forster@med.uni-heidelberg.de.
Philippe FederspilDepartment of Otorhinolaryngology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. philippe.federspil@med.uni-heidelberg.de.ORCID 0000-0002-2537-0185
Klaus HerfarthDepartment of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. klaus.herfarth@med.uni-heidelberg.de.
Peter PlinkertDepartment of Otorhinolaryngology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. peter.pinkert@med.uni-heidelberg.de.
Juergen DebusDepartment of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. juergen.debus@med.uni-heidelberg.de.
Sebastian AdebergDepartment of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. sebastian.adeberg@med.uni-heidelberg.de.ORCID 0000-0001-8463-514X
Heidelberg University · DEGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to evaluate the treatment outcome of primary and postoperative bimodal radiotherapy (RT) including intensity modulated photon radiotherapy (IMRT) and carbon ion radiotherapy (CIRT) for sinonasal adenoid cystic carcinoma (ACC) patients. Medical records of 227 consecutive patients who received either a primary (

Indexed as

adenoid cystic carcinomacarbon ion radiotherapylocal controlrecurrence patternssinonasal carcinomatoxicity

Identifiers

PMID31683896
PMCPMC6895865
OpenAlexW2987119357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.